These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35279809)

  • 1. Gender-specific soluble α-klotho levels as marker of GH deficiency in children: a case-control study.
    Guarnotta V; Pizzolanti G; Petrancosta R; Radellini S; Baiamonte C; Giordano C
    J Endocrinol Invest; 2022 Jun; 45(6):1247-1254. PubMed ID: 35279809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency.
    Ciresi A; Cicciò F; Radellini S; Giordano C
    Growth Horm IGF Res; 2016 Aug; 29():71-77. PubMed ID: 27235725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency.
    Ciresi A; Radellini S; Vigneri E; Guarnotta V; Bianco J; Mineo MG; Giordano C
    J Endocrinol Invest; 2018 Mar; 41(3):333-342. PubMed ID: 28819906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-hour post-load plasma glucose level is associated with a worse metabolic profile in children with GH deficiency.
    Ciresi A; Giordano C
    J Endocrinol Invest; 2018 Jul; 41(7):789-797. PubMed ID: 29249018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment.
    Chaler EA; Rivarola MA; Guerci B; Ciaccio M; Costanzo M; Travaglino P; Maceiras M; Pagani S; Meazza C; Bozzola E; Barberi S; Bozzola M; Belgorosky A
    Horm Res; 2006; 66(5):231-5. PubMed ID: 16912509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the underlying etiology of growth hormone deficiency on serum IGF-I SDS levels during GH treatment in children.
    Léger J; Mohamed D; Dos Santos S; Ben Azoun M; Zénaty D; Simon D; Paulsen A; Martinerie L; Chevenne D; Alberti C; Carel JC; Guilmin-Crepon S
    Eur J Endocrinol; 2017 Sep; 177(3):267-276. PubMed ID: 28760908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Alpha Klotho in Acromegaly: Comparison With Traditional Markers of Disease Activity.
    Schweizer JROL; Schilbach K; Haenelt M; Giannetti AV; Bizzi MF; Soares BS; Paulino E; Schopohl J; Störmann S; Ribeiro-Oliveira A; Bidlingmaier M
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2887-e2899. PubMed ID: 33864468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Changes across Tertiles of Delta Changes in Height SDS during Growth Hormone Therapy in Children with Growth Hormone Deficiency.
    Giannini C; Mastromauro C; Polidori N; Chiarelli F; Mohn A
    Horm Res Paediatr; 2022; 95(5):415-422. PubMed ID: 35772388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic outcomes of growth hormone treatment in children are gender specific.
    Ciresi A; Radellini S; Guarnotta V; Mineo MG; Giordano C
    Endocr Connect; 2018 Jul; 7(7):879-887. PubMed ID: 29925523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.